Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-20 Purchase | 2023-03-22 4:01 pm | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 10,000 | $2.5 | $25,000 | 22,721 (Direct) | View |
| 2019-07-01 Sale | 2019-07-03 4:28 pm | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 639 | $2.35 | $1,502 | 51,969 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-01 Tax Withholding | 2024-04-03 5:04 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya CHIEF LEGAL OFFICER AND GC | 161 | $3.08 | 149,274 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:20 pm | N/A 2033-12-31 | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 62,500 | $0 | 211,935 (Direct) | View |
| 2024-01-02 Tax Withholding | 2024-01-03 5:20 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 161 | $2.28 | 211,935 (Direct) | View |
| 2023-12-13 Option Award | 2023-12-15 5:09 pm | N/A 2033-12-12 | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 62,500 | $0 | 149,596 (Direct) | View |
| 2023-10-02 Tax Withholding | 2023-10-04 4:21 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 1,154 | $3.83 | 24,596 (Direct) | View |
| 2023-06-30 Tax Withholding | 2023-07-05 4:32 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 157 | $4.1 | 25,750 (Direct) | View |
| 2023-06-08 Disposition | 2023-06-08 4:17 pm | N/A N/A | Satsuma Pharmaceuticals Inc. | STSA | Harsch Mutya Director | 70,000 | $0 | 0 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 4:34 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 3,664 | $3.4563 | 25,907 (Direct) | View |
| 2023-03-31 Tax Withholding | 2023-04-04 5:03 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 478 | $3.08 | 22,243 (Direct) | View |
| 2022-12-31 Tax Withholding | 2023-01-04 5:12 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 1,813 | $0.15 | 229,144 (Direct) | View |
| 2022-09-30 Tax Withholding | 2022-10-04 5:04 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 1,813 | $0.223 | 230,957 (Direct) | View |
| 2022-06-30 Tax Withholding | 2022-07-05 5:00 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 1,813 | $0.389 | 232,770 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-07 5:36 pm | N/A 2032-06-02 | Satsuma Pharmaceuticals Inc. | STSA | Harsch Mutya Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-03-31 Tax Withholding | 2022-04-04 5:09 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 3,630 | $0.65 | 234,583 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-18 5:09 pm | N/A 2032-03-17 | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 75,000 | $0 | 313,213 (Direct) | View |
| 2021-12-31 Tax Withholding | 2022-01-04 4:40 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 1,484 | $1.02 | 163,213 (Direct) | View |
| 2021-10-11 Option Award | 2021-10-12 5:17 pm | N/A 2031-10-11 | Satsuma Pharmaceuticals Inc. | STSA | Harsch Mutya Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-09-30 Tax Withholding | 2021-10-01 5:11 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 1,484 | $1.39 | 164,697 (Direct) | View |
| 2021-09-02 Option Award | 2021-09-03 5:34 pm | N/A 2031-09-02 | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 121,719 | $0 | 227,041 (Direct) | View |
| 2021-06-30 Tax Withholding | 2021-07-02 4:36 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 3,551 | $3.51 | 105,322 (Direct) | View |
| 2021-03-31 Tax Withholding | 2021-04-02 12:14 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 1,765 | $6.84 | 108,873 (Direct) | View |
| 2021-02-22 Option Award | 2021-02-24 4:38 pm | N/A 2031-02-22 | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 97,375 | $0 | 178,800 (Direct) | View |
| 2020-12-31 Tax Withholding | 2021-01-05 4:32 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 1,822 | $1.58 | 325,703 (Direct) | View |
| 2020-11-30 Option Award | 2020-12-02 4:31 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 10,460 | $1.445 | 327,525 (Direct) | View |
| 2020-09-30 Tax Withholding | 2020-10-02 4:31 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 1,822 | $1.66 | 317,065 (Direct) | View |
| 2020-06-30 Tax Withholding | 2020-07-02 4:24 pm | N/A N/A | Menlo Therapeutics Inc. | MNLO | Harsch Mutya Chief Legal Officer and GC | 1,822 | $1.73 | 318,887 (Direct) | View |
| 2020-05-06 Option Award | 2020-05-08 5:53 pm | N/A 2030-05-06 | Menlo Therapeutics Inc. | MNLO | Harsch Mutya Chief Legal Officer and GC | 150,000 | $0 | 470,712 (Direct) | View |
| 2020-04-06 Tax Withholding | 2020-04-07 5:22 pm | N/A N/A | Menlo Therapeutics Inc. | MNLO | Harsch Mutya Chief Legal Officer and GC | 4,474 | $1.4 | 170,712 (Direct) | View |
| 2020-04-03 Option Award | 2020-04-07 5:22 pm | N/A N/A | Menlo Therapeutics Inc. | MNLO | Harsch Mutya Chief Legal Officer and GC | 118,683 | $0 | 170,712 (Direct) | View |
| 2020-03-31 Tax Withholding | 2020-04-02 4:47 pm | N/A N/A | Menlo Therapeutics Inc. | MNLO | Harsch Mutya Chief Legal Officer and GC | 1,688 | $2.68 | 56,503 (Direct) | View |
| 2020-03-09 Option Award | 2020-03-11 5:56 pm | N/A 2028-02-27 | Menlo Therapeutics Inc. | MNLO | Harsch Mutya Chief Legal Officer and GC | 186,540 | $0 | 186,540 (Direct) | View |
Ownership | 2020-03-11 5:52 pm | N/A N/A | Menlo Therapeutics Inc. | MNLO | Harsch Mutya Chief Legal Officer and GC | 0 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:39 pm | N/A 2028-02-27 | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 314,894 | $0 | 0 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-03 4:38 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 1,761 | $2.6775 | 98,232 (Direct) | View |
| 2020-02-24 Option Award | 2020-02-24 6:38 pm | N/A 2030-02-24 | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 137,664 | $0 | 192,836 (Direct) | View |
| 2019-12-31 Tax Withholding | 2020-01-03 5:23 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 618 | $3.28 | 55,172 (Direct) | View |
| 2019-11-29 Option Award | 2019-12-03 4:30 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 4,284 | $2.159 | 55,790 (Direct) | View |
| 2019-09-30 Tax Withholding | 2019-10-02 4:19 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 463 | $3.07 | 51,506 (Direct) | View |